CD40 is a member of the tumor necrosis factor receptor superfamily. The int
eraction between CD40 and CD40 ligand (CD154) activates NF-kappaB, Jun N-te
rminal kinase, and Janus kinase/signal transducers and activators of transc
ription pathways and promotes B cell growth, differentiation, and survival
as well as IL-12 production in macrophages and dendritic cells. We demonstr
ate here the existence of multiple isoforms of CD40 mRNA generated by alter
native splicing and show that their expression is regulated differentially
in activated macrophages and dendritic cells. Pre-CD40 RNA is spliced prefe
rentially out to signal-transducible CD40 mRNA in the early stage of activa
tion; half of the CD40 mRNA is replaced by the signal-nontransducible CD40
mRNAs in the later stages (24 h), Using IL-12 p40 gene expression as a repo
rter for CD40 signaling, we show that three of the alternative isoforms can
disable signaling through CD40, The major alternative isoform lacks the me
mbrane-associated endodomain and seems to reduce the amount of the signal-t
ransducible form available on the cell surface. It would seem, therefore, t
hat CD40 expression is controlled by posttranscriptional and posttranslatio
nal regulation through alternative splicing. Modulation of isoform expressi
on may provide a mechanism by which cells regulate their susceptibility to
CD40L signaling.